Unlock the secrets to a healthier you

Today I was reading on HIV/AIDS treatment and I found a fascinating news about the new treatment. There was a conference which was held in Chicago, the name of conference was " Inter-science  Conference on Antimicrobial Agents and Chemotherapy".  According to the researchers they said that they have found a way to protect the T-Cells through cell based therapy, when HIV/AIDS virus attacks the human body it's primary target is T-cells.  Scientists have found a way to protect the T-cells from HIV/AIDS virus. What I have found is that the CEO of Sangamo's who is Edward says in these words " The data are very encouraging"  and I hope so it's the case :).

According to researcher at "The Lancet" they published a issue on Friday, they say that a drug, known as Rilpivirine can help control the HIV when it is combined with other drugs, it can't cure HIV/AIDS yet, but it can greatly suppress the HIV infection. This drug which is produced by Tibotec which is very famous pharmaceutical company and drug is marketed under the name of Edurant. Tibotec says that this drug is safe and effective, and it has very less side effects when it is compared with Efavirenz, which is presently used to suppress the HIV infection. In May 2011 this drug was approved by FDA ( United States Food and Drug Administration ). From 1981 to present the HIV/AIDS has taken almost thirty million lives so far, this drug Rilpivirine can be a new mile stone in fight against HIV/AIDS.